RoSiRo
ActiveSummary
RoSiRo has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €160,071. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 89% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
05-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
Financial
Equity above €1mequity €1.1m ▲17.3%
A profit in every financial year since 2020 builds equity to €1.1m.
30-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-06
Financial
Weakest financial yearnet €98,243 ▼35.5%
Net result drops to €98,243, the lowest in the series; recovery starts the following year.
30-06
Financial
Liquidity more than doubledcurrent ratio 8.16
Current ratio from 3.88 to 8.16; short-term debt falls from €199,279 to €91,836.
30-01
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
10-02
NBB filing
Annual accounts filed
financial year 2022 · micro format · 10 days late
2022
30-06
Financial
Highest result from 2020 to 2025net €300,020 ▲45.1%
Operating result €393,107, net result €300,020, both a record.
30-06
Financial
Equity above €500,000equity €674,392 ▲80.1%
A profit in every financial year since 2020 builds equity to €674,392.
31-01
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
30-06
Financial
Equity above €200,000equity €374,371 ▲123%
A profit in every financial year since 2020 builds equity to €374,371.
18-02
NBB filing
Annual accounts filed
financial year 2020 · micro format · 18 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.